NCT07722663

Brief Summary

This single-center, two-phase cohort study aimed to develop and validate a simple endoscopic classification of fundoplication integrity after anti-reflux surgery (ARS - Nissen or Toupet fundoplication). Consecutive adult patients undergoing endoscopy, high-resolution manometry (HRM), and reflux monitoring after ARS were included. Retroflexed endoscopic videoclips were reviewed blinded to clinical and functional results. In the development cohort (2018-2024, n=73), individual endoscopic parameters were tested against pathologic GERD (Lyon 2.0 criteria). Three parameters significantly correlated with pathologic reflux: (1) intrathoracic valve location, (2) disrupted valve (deep anterior and/or posterior grooves), and (3) visible hiatal opening. Patients were stratified according to the number of impaired mechanisms (0-3). Symptom burden, manometric abnormalities, and reflux metrics worsened progressively with increasing impairment. The rate of pathologic GERD rose from 11.8% (0 mechanisms) to 37.5% (1-2 mechanisms) to 85.7% (3 mechanisms). The classification was then prospectively validated in an independent cohort (2024-2026, n=49), reproducing the same stepwise correlation. The number of impaired mechanisms showed excellent discriminatory capacity for pathologic GERD (AUC 0.860 in development, 0.870 in validation; overall AUC 0.869). This simple endoscopic classification, based on only three objective parameters, reliably identifies fundoplication failure and correlates with symptoms and objective pathophysiologic data. It has the potential to standardize endoscopic reporting after ARS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
153

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2018

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

July 19, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 23, 2026

Completed
Last Updated

July 27, 2026

Status Verified

July 1, 2026

Enrollment Period

8 years

First QC Date

July 19, 2026

Last Update Submit

July 24, 2026

Conditions

Keywords

endoscopypH studyanti-reflux surgery

Outcome Measures

Primary Outcomes (1)

  • acid exposure time

    time of pH\<4 during the pH monitoring test

    during pH impedance monitoring

Study Arms (3)

Normal fundoplication

Patients with 0 impaired mechanisms of ARB restoration

Partially impaired fundoplication

Patients with 1-2 impaired mechanisms of ARB restoration

Fully impaired fundoplication

Patients with 3 impaired mechanisms of ARB restoration

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent anti-reflux surgery and a complete manometric, reflux monitoring and endoscopic assessment

You may qualify if:

  • Adults (18-90 years)
  • Previous Nissen or Toupet fundoplication for GERD or large hiatal hernia
  • Completion of post-operative esophagogastroduodenoscopy (EGD)
  • Adequate retroflexed endoscopic videoclip
  • Post-operative High-resolution manometry (HRM) and reflux monitoring (MII-pH or wireless pH)

You may not qualify if:

  • Other foregut operations (Dor, Collis, magnetic sphincter augmentation, bariatric surgery)
  • Insufficient quality of endoscopic videoclips
  • Missing HRM or reflux monitoring

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Policlinico San Donato

San Donato Milanese, Milan, 20097, Italy

Location

MeSH Terms

Conditions

Gastroesophageal Reflux

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
3 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MEDICAL DOCTOR

Study Record Dates

First Submitted

July 19, 2026

First Posted

July 23, 2026

Study Start

April 1, 2018

Primary Completion

April 1, 2026

Study Completion

July 1, 2026

Last Updated

July 27, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations